Cargando…

Obesity, Inflammation, and Prostate Cancer

The prevalence of obesity is increasing in the world, and obesity-induced disease, insulin-resistance, cardiovascular disease, and malignancies are becoming a problem. Epidemiological studies have shown that obesity is associated with advanced prostate cancer and that obese men with prostate cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Kazutoshi, Hayashi, Takuji, Matsushita, Makoto, Uemura, Motohide, Nonomura, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406330/
https://www.ncbi.nlm.nih.gov/pubmed/30736371
http://dx.doi.org/10.3390/jcm8020201
_version_ 1783401276406497280
author Fujita, Kazutoshi
Hayashi, Takuji
Matsushita, Makoto
Uemura, Motohide
Nonomura, Norio
author_facet Fujita, Kazutoshi
Hayashi, Takuji
Matsushita, Makoto
Uemura, Motohide
Nonomura, Norio
author_sort Fujita, Kazutoshi
collection PubMed
description The prevalence of obesity is increasing in the world, and obesity-induced disease, insulin-resistance, cardiovascular disease, and malignancies are becoming a problem. Epidemiological studies have shown that obesity is associated with advanced prostate cancer and that obese men with prostate cancer have a poorer prognosis. Obesity induces systemic inflammation via several mechanisms. High-fat diet-induced prostate cancer progresses via adipose-secretory cytokines or chemokines. Inflammatory cells play important roles in tumor progression. A high-fat diet or obesity changes the local profile of immune cells, such as myeloid-derived suppressor cells and macrophages, in prostate cancer. Tumor-associated neutrophils, B cells, and complements may promote prostate cancer in the background of obesity. Interventions to control systemic and/or local inflammation and changes in lifestyle may also be viable therapies for prostate cancer.
format Online
Article
Text
id pubmed-6406330
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-64063302019-03-22 Obesity, Inflammation, and Prostate Cancer Fujita, Kazutoshi Hayashi, Takuji Matsushita, Makoto Uemura, Motohide Nonomura, Norio J Clin Med Review The prevalence of obesity is increasing in the world, and obesity-induced disease, insulin-resistance, cardiovascular disease, and malignancies are becoming a problem. Epidemiological studies have shown that obesity is associated with advanced prostate cancer and that obese men with prostate cancer have a poorer prognosis. Obesity induces systemic inflammation via several mechanisms. High-fat diet-induced prostate cancer progresses via adipose-secretory cytokines or chemokines. Inflammatory cells play important roles in tumor progression. A high-fat diet or obesity changes the local profile of immune cells, such as myeloid-derived suppressor cells and macrophages, in prostate cancer. Tumor-associated neutrophils, B cells, and complements may promote prostate cancer in the background of obesity. Interventions to control systemic and/or local inflammation and changes in lifestyle may also be viable therapies for prostate cancer. MDPI 2019-02-06 /pmc/articles/PMC6406330/ /pubmed/30736371 http://dx.doi.org/10.3390/jcm8020201 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Fujita, Kazutoshi
Hayashi, Takuji
Matsushita, Makoto
Uemura, Motohide
Nonomura, Norio
Obesity, Inflammation, and Prostate Cancer
title Obesity, Inflammation, and Prostate Cancer
title_full Obesity, Inflammation, and Prostate Cancer
title_fullStr Obesity, Inflammation, and Prostate Cancer
title_full_unstemmed Obesity, Inflammation, and Prostate Cancer
title_short Obesity, Inflammation, and Prostate Cancer
title_sort obesity, inflammation, and prostate cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406330/
https://www.ncbi.nlm.nih.gov/pubmed/30736371
http://dx.doi.org/10.3390/jcm8020201
work_keys_str_mv AT fujitakazutoshi obesityinflammationandprostatecancer
AT hayashitakuji obesityinflammationandprostatecancer
AT matsushitamakoto obesityinflammationandprostatecancer
AT uemuramotohide obesityinflammationandprostatecancer
AT nonomuranorio obesityinflammationandprostatecancer